VHIValhi, Inc.
Is the price fair?
Neither cheap nor expensive: modest expectations priced in, but at the top of its own P/E range.
Priced for a decline (~−9% a year). The price demands less than its three-year revenue growth of 3% a year, expectations look modest.
Expensive vs its own history: P/E 24.2 vs a 8.3 median over 27 quarters (+190% vs median).
Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.
What VHI's price assumes
Valhi, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 0.19× revenue.
Price / sales · no P/E: the last twelve months did not end in a profit
- Free cash flow yield
- 15%
Free cash flow yield · Chemicals median 13%
- Growth the price implies
- −8.9%
Growth the price implies · The price pays for −8.9% free cash flow growth a year for a decade; revenue has grown +3.4% a year over the last three.
- Price / book
- 0.39
Price / book · as of 2026-Q1
Details›
- Price / bookas of 2026-Q1
- 0.39
- EV / salesas of 2026-Q1
- 0.41
- Free cash flow, trailing twelve months
- $63M
- Market capitalisation
- $429M
- 3-year revenue growth
- +3.4%
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.